Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
11.57
+0.04 (0.35%)
Aug 4, 2026, 3:00 PM CST

SHA:603739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
230.01244.16248.73239.6213.87311.83
Trading Asset Securities
267.37224.87199.34292.05212.02170.43
Cash & Short-Term Investments
497.38469.02448.07531.64425.89482.27
Cash Growth
5.38%4.68%-15.72%24.83%-11.69%38.83%
Accounts Receivable
406.39409.27376.58330.26307.72254.31
Other Receivables
45.8441.9728.6825.8332.5136.3
Receivables
452.24460.24405.26356.09347.91298.37
Inventory
230.52226.37188.95205.41173.63157.02
Prepaid Expenses
-01.590.120.130.06
Other Current Assets
57.8522.9825.3130.6821.8434.1
Total Current Assets
1,2381,1791,0691,124969.4971.82
Property, Plant & Equipment
1,4921,5241,5601,5051,260843.51
Long-Term Investments
74.7676.2598.6480.8477.198.59
Goodwill
84.284.284.284.220.2620.26
Other Intangible Assets
129.29126.72131.13139.74135.63131.46
Long-Term Deferred Tax Assets
24.4923.5516.9918.0613.6412.03
Long-Term Deferred Charges
1.471.261.471.411.280.37
Other Long-Term Assets
32.0125.5419.1480.57101.57233.72
Total Assets
3,0763,0402,9813,0342,5792,222

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
215.8194.41224.56231.95147.36112.11
Accrued Expenses
19.27116.92102.0991.7674.2672.89
Short-Term Debt
620.43582.87581.63568.97374.22135.93
Current Portion of Long-Term Debt
26.0236.1240.0392.88-1
Current Income Taxes Payable
17.448.3410.068.4311.678.95
Current Unearned Revenue
22.7214.2511.5110.677.4913.62
Other Current Liabilities
118.8754.1761.5783.5130.127.83
Total Current Liabilities
1,0411,0071,0311,088645.09372.33
Long-Term Debt
50.0659.7913.9662.0614999
Long-Term Unearned Revenue
56.0959.5863.9755.2647.9660.45
Long-Term Deferred Tax Liabilities
2.211.381.463.022.722.88
Other Long-Term Liabilities
1.111.110.150.150.171.52
Total Liabilities
1,1501,1291,1111,209844.93536.18

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
253.03253.03253.03253.03252.44252.08
Additional Paid-In Capital
702.9702.9702.9712.08705.09693.84
Retained Earnings
858.99841.4796.9759.56704.12674.61
Comprehensive Income & Other
-15.17-14.81-15.1-16.38-16.96-16.03
Total Common Equity
1,8001,7831,7381,7081,6451,605
Minority Interest
126.36128.2132.3117.0989.2281.07
Shareholders' Equity
1,9261,9111,8701,8251,7341,686
Total Liabilities & Equity
3,0763,0402,9813,0342,5792,222

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
696.51678.78635.62723.92523.22235.93
Net Cash (Debt)
-199.13-209.76-187.55-192.27-97.33246.34
Net Cash Growth
------11.88%
Net Cash Per Share
-0.79-0.84-0.75-0.76-0.381.00
Filing Date Shares Outstanding
253.03253.03253.03253.03252.62252.08
Total Common Shares Outstanding
253.03253.03253.03253.03252.44252.08
Working Capital
197.43171.5337.7535.77324.31599.5
Book Value Per Share
7.117.046.876.756.526.36
Tangible Book Value
1,5861,5721,5221,4841,4891,453
Tangible Book Value Per Share
6.276.216.025.875.905.76
Buildings
-1,009932.34931.6449.85398.83
Machinery
-1,095943.65929.21474.19443.58
Construction In Progress
-37.4203.8175.14704.43315.72